Hardware leads the rehabilitation exoskeletons market at 68.0% share by component, followed by lower-limb gait exoskeletons at 52.0% by type and stroke rehabilitation at 38.0% by application. Adoption hinges on improving patient mobility and rehabilitation outcomes, while high costs and limited access remain key constraints.